AzTrials
AzTrials

LaparotomyPhase 2/3CONTINTNCT00544583

Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy

A Phase 2/3 study testing Interrupted sutures and Continuous sutures in people with Laparotomy and Hernia, run by Heidelberg University at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients undergoing primary midline laparotomy for an emergency surgical intervention with a suspected septic focus in the abdominal cavity. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Laparotomy, Hernia
What is being tested?
Interrupted sutures and Continuous sutures
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteGermany
Study dates
Nov 2007to Apr 2012
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Preoperative Inclusion criteria:
  • Age equal or greater than 18 years
  • Expected survival time more than 12 months
  • Patients undergoing primary and emergency midline laparotomy (patients with prior laparoscopy (not colon resections) or minor abdominal operation (e.g. appendectomy, cholecystectomy, hysterectomy, sectio) may be included into the trial)
  • Suspected septic abdominal focus (e.g. perforated stomach ulcer, perforated diverticulitis)
  • Informed consent
Show all 9Show fewer
  • Intraoperative inclusion criteria before closure:
  • Successful source control
  • Abdominal lavage

Who cannot join

  • Preoperative exclusion criteria:
  • Participation in another intervention-trial with interference of intervention and outcome of this study
  • Intraoperative exclusion criteria before closure:
  • Planned re-laparotomy

Trial locations and contacts

1 site in 1 country.

Germany1 site, 1 recruiting
  • Department of Surgery

    Heidelberg, 69120

    Nuh N Rahbari, MD, + 49 6221 56 39448, nuh.rahbari@med.uni-heidelberg.de

    SDGC Heidelberg, +49 6221 56 6986, sdgc@med.uni-heidelberg.de

    Recruiting

Other trials in Germany

About this study

Official title: Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy: CONTINT - A Randomized Controlled Study

Patients undergoing primary midline laparotomy for an emergency surgical intervention with a suspected septic focus in the abdominal cavity.

Read the detailed description

More than 700.000 open abdominal surgeries (laparotomies) are performed each year in Germany (2). A major surgical complication after laparotomy is abdominal fascia dehiscence which might appear either as early (burst abdomen with evisceration) or as late complication (incisional hernia). These patients usually undergo surgery for secondary fascial closure associated with markedly increased morbidity (3) including high recurrence rates (up to 45%) (4). The applied surgical strategy of abdominal wall closure (i.e. the combination of suture technique and material) is of high relevance for prevention of fascia dehiscence and, moreover, constitutes the main factor directly controllable by the surgeon. While several randomized controlled trials (RCT) (3; 5-8) as well as meta-analyses (9-12) exist that address the issue of optimal fascia closure in elective laparotomies, there is no RCT dealing exclusively with the emergency setting. As a result abdominal fascia closure is performed according to the surgeon's individual preference rather than according to evidence-based data. Therefore, the present RCT is designed to compare the most established strategies (continuous slowly absorbable sutures and interrupted rapidly absorbable sutures) for abdominal wall closure in order to determine differences between both strategies after midline incisions.

Conditions
Laparotomy, Hernia
Being tested
Interrupted sutures, Continuous sutures
Keywords
Abdominal wall
Medical subject headings
Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interrupted suturesProcedure or surgery

    Interrupted sutures for abdominal fascia closure with Vicryl equivalent sutures (USP 2, 45 cm)

  • Continuous suturesProcedure or surgery

    Continuous sutures for abdominal fascia closure with PDS II equivalent USP 1, 150 cm loops

Study groups in NCT00544583
Study groupRoleWhat they receive
AActive comparatorInterrupted closure with Vicryl equivalent sutures (USP 2, 45 cm)
Receives: Procedure: Interrupted sutures
BExperimentalContinuous closure with PDS II equivalent sutures (USP 1, 150 cm loops)
Receives: Procedure: Continuous sutures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incisional hernia or burst abdomen within 12 months

    Measured: 12 months

Secondary outcomes (1)
  1. Quality of Life

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2007 (estimated)
  2. Study startNov 2007
  3. Primary completionApr 2011 (estimated)
  4. Study completionApr 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00544583
Sponsor's protocol ID
S206/2007
Acronym
CONTINT
Status last verified
Jan 2010
First submitted
15 Oct 2007
Last updated
27 Jan 2010
Results posted
No
Data monitoring committee
Yes

Publications

  • Rahbari NN, Knebel P, Kieser M, Bruckner T, Bartsch DK, Friess H, Mihaljevic AL, Stern J, Diener MK, Voss S, Rossion I, Buchler MW, Seiler CM. Design and current status of CONTINT: continuous versus interrupted abdominal wall closure after emergency midline laparotomy - a randomized controlled multicenter trial [NCT00544583]. Trials. 2012 May 30;13:72. doi: 10.1186/1745-6215-13-72.

    PubMed 22647387

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Interrupted sutures and Continuous sutures in people with Laparotomy and Hernia, run by Heidelberg University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jan 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nuh N Rahbari, MD (+49 6221 56 39448, nuh.rahbari@med.uni-heidelberg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incisional hernia or burst abdomen within 12 months (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00544583, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in